Mimura, Osamu
Ishikawa, Hitoshi
Kezuka, Takeshi
Shikishima, Keigo
Suzuki, Tone
Nakamura, Makoto
Chuman, Hideki
Inoue, Kenji
Kimura, Akiko
Yamagami, Akiko
Mihoya, Maki
Nakao, Yuzo
Article History
Received: 24 December 2019
Accepted: 12 October 2020
First Online: 20 January 2021
Conflicts of interest
: O. Mimura, Grant (Teijin), Lecture fee (Santen, Senju, Otsuka, Pfizer, Alcon, GSK); H. Ishikawa, Grant (Teijin), Grant-in-aid for Scientific Research from Ministry of Health, Labor and Welfare 2015–2017 (Research Project on Intractable Diseases Policy); T. Kezuka, Grant, Financial support (Teijin), Financial support (AbbVie, Alcon, Cosmic Corp, Eisai, Kowa, Mitsubishi Tanabe, Santen, Senju), Non-Financial support (Cosmic Corp); K. Shikishima, Grant (Teijin), Honorarium for Speaker (Santen, Senju, Johnson & Johnson, Chugai, Cosmic Corp), T. Suzuki, Grant (Teijin); M. Nakamura, Grant (Teijin); H. Chuman, Grant (Teijin); K. Inoue, Grant (Teijin), Grant, Research support, Lecture fee, Writing assistance, Consultant fee (Santen), Research support (Alcon), Lecture fee (Otsuka), Grant, Research support, Lecture fee, Consultant fee (Senju), Lecture fee, Consultant fee (Kowa), Grant, Research support, Lecture fee (Allergan), Lecture fee (Novartis, Wakamoto), Research support (IQVIA, Mayo Corp, Lilly); A. Kimura, Grant (Teijin); A. Yamagami, Grant (Teijin); M. Mihoya, Employee (Teijin), Y. Nakao, Grant (Teijin).